The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A window of opportunity trial for metastatic (WOO-M) pancreatic ductal adenocarcinoma (PDAC): A biomarker discovery platform.
 
Charles D. Lopez
Research Funding - Roche/Genentech (Inst); Taiho Pharmaceutical
 
Adel Kardosh
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; Eisai; Exelixis; Exelixis; Genentech
Research Funding - Natera
 
Emerson Yu-sheng Chen
Other Relationship - Horizon CME; Taiho Pharmaceutical
 
Guillaume Joe Pegna
Stock and Other Ownership Interests - Amryt Pharma
 
Alexander Guimaraes
Honoraria - Agfa Healthcare
Consulting or Advisory Role - BioClinica; Calyx; Merck; Takeda
Expert Testimony - Witherspoon Kelly
 
Bryan Foster
No Relationships to Disclose
 
Brian Brinkerhoff
No Relationships to Disclose
 
Shaun Goodyear
Consulting or Advisory Role - PDX Pharmacy
 
Erin Taber
No Relationships to Disclose
 
Brindha Rajagopalan
No Relationships to Disclose
 
Johnson Vo
No Relationships to Disclose
 
Kiara Siex
No Relationships to Disclose
 
Brett Johnson
No Relationships to Disclose
 
Danielle Galipeau
No Relationships to Disclose
 
Sidney Huszti
No Relationships to Disclose
 
Dove Keith
No Relationships to Disclose
 
Brett C. Sheppard
No Relationships to Disclose
 
Jonathan Brody
No Relationships to Disclose
 
Rosalie C. Sears
Consulting or Advisory Role - Larkspur; Novartis; Rappta Therapeutics
Research Funding - Cardiff Oncology (Inst)
Travel, Accommodations, Expenses - Rappta Therapeutics
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; ImmunoMET; SignalChem; Tarveda Therapeutics; Turbine
Consulting or Advisory Role - AstraZeneca; BlueDot; Chrysalis Biotherapeutics; Ellipses Pharma; ImmunoMET; Infinity Pharmaceuticals; Ionis Pharmaceuticals; Lilly; MedaCorp; NanoString Technologies; PDX Pharmacy; SignalChem; Tarveda Therapeutics; Turbine; Zentalis
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Breast Cancer Research Foundation; Genentech; GlaxoSmithKline; Komipharm; Lilly; NanoString Technologies; Ovarian Cancer Research Foundation; Prospect Creek Foundation
Patents, Royalties, Other Intellectual Property - Myriad Genetics; NanoString Technologies